Introduction to the opening symposium “genetics in atherosclerosis research” G. Schettler OriginalPaper Pages: 1 - 2
Application of cladistics to the analysis of genotype-phenotype relationships C. F. SingM. B. HavilandA. R. Templeton OriginalPaper Pages: 3 - 9
Phenotypic heterogeneity associated with defective apolipoprotein B-100 and occurrence of the familial hypercholesterolemia phenotype in the absence of an LDL-receptor defect within a Canadian kindred J. DavignonR. DufourS. Lussier-Cacan OriginalPaper Pages: 10 - 17
RFLPs of the LDL-receptor gene: Their use in the diagnosis of FH and in evaluation of different levels of gene expression on normal subjects S. BertoliniD. A. CovielloS. Humphries OriginalPaper Pages: 18 - 25
Characterization of a family with moderate hypercholesterolemia and binding defective low density lipoprotein A. L. CatapanoA. CorsiniR. Fumagalli OriginalPaper Pages: 26 - 32
LP(A) and the risk of coronary heart disease M. Bihari-VargaG. KostnerA. Czinner OriginalPaper Pages: 33 - 35
Aortic features in tangier disease and pathogenetic considerations — Part I. Fatty dots and streaks M. D. Haust OriginalPaper Pages: 36 - 47
Serum lipoprotein profile in the Mediterranean variant of glucose-6-phosphate dehydrogenase deficiency S. MuntoniB. BatettaP. Pani OriginalPaper Pages: 48 - 53
Association of a polymorphism in the apo AI gene promoter with hyperalphalipoproteinemia F. PaganiG. A. GiudiciC. Vergani OriginalPaper Pages: 54 - 58
The molecular defects in lipoprotein lipase deficient patients S. S. FojoO. BegH. B. Brewer Jr. OriginalPaper Pages: 59 - 63
Factor VIII and coronary heart disease F. R. Rosendaal Haemostatic function and cardiovascular disease Pages: 71 - 75
LP(A): A link between thrombosis and atherosclerosis A. M. Scanu Haemostatic function and cardiovascular disease Pages: 76 - 78
Plasma fibrinogen and factor VII as risk factors for cardiovascular disease C. C. Kelleher Genetics in Atherosclerotic Research Pages: 79 - 82
Fibrinogen/fibrin in atherogenesis E. B. SmithW. D. ThompsonC. M. Stirk Genetics in Atherosclerosis Research Pages: 83 - 87
Fibrinogen and mechanisms of thrombosis. A difficult link G. Di MinnoA. CerboneM. Mancini OriginalPaper Pages: 88 - 91
IDL, VLDL, chylomicrons and atherosclerosis B. G. NordestgaardA. Tybjærg-Hansen OriginalPaper Pages: 92 - 98
The importance of triglycerides: Results from the prospective cardiovascular Münster (PROCAM) study G. AssmannH. Schulte Haeeostatic function and cardiovascular disease Pages: 99 - 103
Concept of an antiatherosclerotic efficacy of calcium entry blockers S. JostW. RafflenbeulP. Lichtlen OriginalPaper Pages: 107 - 119
Activity profile of gemfibrozil on the major plasma lipoprotein parameters C. R. SirtoriG. FranceschiniL. Calabresi Focus on anti-atherosclerotic therapy Pages: 120 - 124
Atherogenic profiles in insulin-dependent diabetic patients and their treatment I. De Leeuw Haemostatic function and cardiovascular diseases Pages: 125 - 128
ACE-inhibitors and atherosclerosis E. AmbrosioniS. BacchelliC. Borghi Focus on anti-atherosclerosis therapy Pages: 129 - 133
Insulin and atherogenesis R. W. Stout Insulin, atherosclerosis and coronary heart disease Pages: 134 - 135
Insulin resistance — modelling studies I. F. GodslandC. WaltonV. Wynn Insuline, atherosclerosis, and coronary heart disease Pages: 136 - 138